B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling

Scientists derived a dormancy-associated residual tumor cell signature that mirrored the transcriptional response to neoadjuvant therapy in patients and was enriched for extracellular matrix-related pathways.